Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

NCT01356290 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma Recurrent
Ependymoma Recurrent
ATRT Recurrent
Rare CNS Tumor Recurrent

Interventions

DRUG: Bevacizumab
DRUG: Thalidomide
DRUG: Celecoxib
DRUG: Fenofibric acid
DRUG: Etoposide
DRUG: Cyclophosphamide
DRUG: Etoposide phosphate
DRUG: Cytarabine
DRUG: Temozolomide (TMZ)
DRUG: Irinotecan

Sponsor

Medical University of Vienna